As of -----------
What is the ISCHEMIA Study?
- An international comparative effectiveness study
- The purpose of ISCHEMIA is to determine the best way to manage stable ischemic heart disease
- Patients with moderate or severe ischemia on stress test imaging may be eligible for participation
If you are a physician and would like more information, please visit the For Physicians section. If you are a patient and would like to learn more about the ISCHEMIA study, please e-mail firstname.lastname@example.org
Why is the ISCHEMIA Study Important?
Ischemic heart disease (IHD) is the leading cause of death and disability worldwide and affects 17,600,000 Americans, resulting in about 450,000 deaths in the United States annually. Globally, 7.2 million deaths are caused by IHD each year.
Medical therapy (medication and lifestyle changes) should always be used to treat IHD. Many doctors routinely use an invasive approach in addition to medical therapy to treat IHD; however, it is not known if this approach is better than medical therapy alone as the initial treatment of patients with stable ischemic heart disease (SIHD). ISCHEMIA is designed to find the answer. Click here to learn more about the ISCHEMIA study.
Make A Difference In Heart Health - Women in Clinical Trials
Heart disease is the leading cause of death for women. Visit the Women in Clinical Trials webpage to learn more about how you can make a difference.
ISCHEMIA Enrollment Updates
ISCHEMIA Enrollment Updates
As of May 23rd 2017, there are 4,267 participants (pts) randomized worldwide in the ISCHEMIA study. Click here to see the randomizations by country.
Congratulations To Our Top Sites!
|Site name||Region||Study Team||Rand Rate & Total Rands|
|Government Medical College||India||PI: Dr. Sajeev, Dr. Rajesh & Dr. Kumar SC: Anand & Bijith||
|Northwick Park Hospital- Royal Brompton Hospital, London||U.K||PI: Senior SC:Kinsey, Collins, Gurunathan, Hassan, Howard, Kabalakkat & Evans||
|Sri Jayadeva Institute of Cardiovascular Sciences and Research, Banglore-Karnataka||India||PI: Dr. Manjunath & Dr. Moorthy SC: Nataraj& Murthy||
|Brazil||PI: Dr. Hueb SC: Takiuti||
|USA||PI: Dr. Mavromatis SC: Montazeri, Lee & Doan||111 pts,
|Coronary and Structural Heart Diseases Department, Institute of Cardiology, Warsaw||Poland||PI: Prof. Demkow SC: Chojnacka, Freleck & Pracon||110 pts,
|Hospital Universitario La Paz||Spain||PI: Dr. Lopez Sendon SC: Valbuena, Castro, La Paz Mediavilla, Valbuena & Fernandez-Figar|| 99 pts,
|Bakulev Scientific Center for Cardiovascular Surgery||Russia||PI: Dr. L. Bockeria SC: O. Bockeria, & Kudzoeva|| 93 pts,
|Instituto Dante Pazzanese de Cardiologia||Brazil||PI: Dr. Pauloa Smanio SC: Leonardo De Pizzol A. Caetano|| 73 pts,
|Ram Manohar Lohia Hospital||India||PI: Dr. Neeraj Pandit SC: Sheromani, Neeraj, & Yadav|| 72 pts,